Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Spot On Sciences - aVenture Company Research

Spot On Sciences

Spot On Sciences

Spot On Sciences, Inc. is a medical device company innovating in biological fluid sample collection and storage, aiming to simplify processes and reduce costs.

San Francisco, CA, US🇺🇸

Founded

Spot On Sciences, Inc., founded in San Francisco, is a medical device company focused on revolutionizing the collection and storage of biological fluid samples. Their core mission is to simplify and enhance the processes of biospecimen sampling, making it more accessible and cost-effective. The company’s flagship product, HemaSpot™, allows for easy blood sample collection and storage for dried blood spot (DBS) testing. Spot On Sciences targets the global market for in vitro diagnostics, which sees over 20 billion blood tests annually.

Notable affiliated individuals include the company's founders and key investors who have supported its innovative vision. Spot On Sciences has achieved significant milestones, including the successful development and commercialization of HemaSpot™. Their impact is marked by improved sample quality and streamlined logistics in biospecimen handling, benefiting both healthcare providers and patients worldwide.

Spot On Sciences - Similar Companies

Abogen

abogen.com

Tasso

tassoinc.com

iSpecimen

ispecimen.com

Spot On Sciences - Quick Facts

Who are Spot On Sciences' competitors?

Companies similar to Spot On Sciences include Abogen, Tasso, iSpecimen and Sedia Biosciences.

When was Spot On Sciences founded?

Spot On Sciences was founded in 2010.

Where is Spot On Sciences' headquarters located?

Spot On Sciences' headquarters is located in San Francisco, CA, US.

When was Spot On Sciences' last funding round?

Spot On Sciences' most recent funding round was for $750k (USD) in June 2014.

How much disclosed funding has Spot On Sciences raised?

As of Jun 16, 2014, Spot On Sciences has disclosed funding of $750k (USD). Undisclosed round amounts are excluded.

Spot On Sciences - Classification

Industry: Hardware
Ownership: Private
Technology: Biotech

How many employees does Spot On Sciences have?

Spot On Sciences has 11 employees as of Feb 4, 2024.

Geographic Exposure

Global

Revenue: Recurring
Customer: Enterprise
Main Product: Medical Devices

Tags: Biotech

NAICS: 320000Manufacturing
325400Pharmaceutical and Medicine Manufacturing
325000Chemical Manufacturing
325410Pharmaceutical and Medicine Manufacturing
SIC: 5000Wholesale Trade-durable Goods
5040Professional And Commercial Equipment And Supplies
5047Medical, Dental, And Hospital Equipment And Supplies

Show 7 more industry codes

NAICS: 330000Manufacturing
620000Health Care and Social Assistance
623000Nursing and Residential Care Facilities
SIC: 3900Miscellaneous Manufacturing Industries
8000Health Services
8040Offices And Clinics Of Other Health Practitioners
8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

Sedia Biosciences

sediabio.com

Spot Health

spotdx.com

Babson Diagnostics

babsondx.com

Hermes Life Sciences

YourBio Health

yourbiohealth.com

Halcyon Biomedical

Sanguis

sanguiswine.com

Reproductive Solutions

Kepler Diagnostics

keplerdx.com

Sanguine

sanguinebio.com

Starr Life Sciences

Vivebio